Back

Metabolic shift to serine pathway induced by lipids confers oncogenic properties in non-transformed breast cells

Eduardo, M. B.; Cottone, G.; McCloskey, C. W.; Liu, S.; Zappia, M. P.; Benevolenskaya, E. V.; Islam, A. B. M. M. K.; Frolov, M. V.; Palma, F. R.; Gao, P.; Setya, J.; Gao, H.; Xuei, X.; Khokha, R.; Locasale, J.; Bonini, M. G.; Chandel, N. S.; Khan, S. A.; Clare, S. E.

2024-02-23 cancer biology
10.1101/2024.02.21.581404 bioRxiv
Show abstract

A lipid metabolism gene signature is associated with the risk of estrogen negative breast cancer (ER-BC). In vitro, lipid exposure alters histone methylation affecting gene expression and increasing flux through various metabolic reactions; but little is known about the mechanism(s) linking lipids and epigenetic reprogramming with the genesis of ER-BC. Here we show that the metabolism of the medium-chain fatty acid Octanoic Acid (OA) in preference to glucose and glutamine results in a metabolic shift toward the serine pathway increasing the production of SAM, glutathione, and 2-HG, with implications for oncogenesis: SAM production results in epigenetic fostered plasticity leading to reprogramming/selecting cells that express Neural, EMT and BC related genes. 2-HG exposure results in appearance of DNA breaks, potentially consequent to the inhibition of essential demethylases for HR repair. ROS increases shortly after OA exposure and is mitigated by antioxidant defenses, which favors/enables the survival of specific cell subtypes.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.